Senior insider sale
AN2 THERAPEUTICS, INC. — senior position signals high conviction
$6.08M
1.01M shares
What this filing means
READNOUR ROBIN SHANE plans to sell 1.01M shares of AN2 THERAPEUTICS, INC. valued at approximately $6.08M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001972481-26-000263
Director
Since Mar 2022
1.01M
Shares to sell
$6.08M
Approx. market value
1.05M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Owned Shares
Owned Shares
3/25/2022
153.33KOwned Shares
Owned Shares
3/5/2021
133.23KOwned Shares
Owned Shares
10/5/2020
185.50KOwned Shares
Owned Shares
11/19/2019
577.70KTotal acquired1.05M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/25/2022 | Owned Shares Owned Shares | 153.33K | — |
3/5/2021 | Owned Shares Owned Shares | 133.23K | — |
10/5/2020 | Owned Shares Owned Shares | 185.50K | — |
11/19/2019 | Owned Shares Owned Shares | 577.70K | — |
| Total | 1.05M | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
1.01M
Market value
$6.08M
8/17/2026
Total
Units
1.01M
Value
$6.08M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 1.01M | $6.08M | Nasdaq | Planned |
| Total | 1.01M | $6.08M | ||